G6 Materials Launches Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System
Poised to Optimize Graphene Oxide Technology for Air Filtration Applications
Ronkonkoma, New York, USA - TheNewswire – July 12, 2022 - G6 Materials Corp. (“G6” or the “Company”) (TSXV: GGG, OTCQB: GPHBF), a high-tech company with expertise in advanced materials and developing innovative composites for a wide range of industrial uses, today announced the launch and immediate availability of the Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System at www.breatheplus.tech and on Amazon (NASDAQ: AMZN).
- Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System is now available at breatheplus.tech and on Amazon:
- Our advanced air purification system removes microbes1, dust particles, smog, dander, pollen as well as volatile organic compounds (VOC)2 from the air.
- Antiviral and antibacterial efficacy verified by independent tests by The Intertek Group.1
- Our patented Graphene Filter removes 99.9% of the pathogenic microorganisms.
- Optimized for spaces up to 1,500 sq. ft., making it perfect for the home and office.
- Our patented air filtration technology could tap into an estimated US$ 25.97 billion market
The Breathe+ Pro Air Purifier utilizes innovative air filters that contain activated carbon with graphene oxide coating (“Graphene Filter”) developed by G6’s research team. This coating is designed to enhance the efficacy of the air filter in capturing bioaerosol particles. As supported by a wealth of scientific knowledge, graphene oxide exhibits profound antibacterial and antiviral properties. Besides the activated carbon with graphene coating, the Breathe+ Pro air purifier also includes a pre-filter, a medical-grade H13 True HEPA filter, as well as an activated carbon filter.
The antiviral and antimicrobial efficacy of the Breathe+ Pro Air Purifier was verified by independent testing conducted by The Intertek Group plc ("Independent Lab Test”) and previously reported in a G6 news release on September 7, 2021. According to the results of the Independent Lab Test, the Breathe+ Pro Air Purifier equipped with Graphene Filter removed 99.9% of the pathogenic microorganisms (model viruses and bacteria) over the duration of the test.
Breathe+ Pro performs multiple air changes per hour to effectively remove pathogens, dust, and other harmful contaminants. It is optimized for large spaces up to 1,500 sq. ft., making it an ideal solution for residential and commercial spaces like classrooms, offices, kitchens, basements, warehouses, and large living rooms.
The Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System is a showcase of the Company’s pending patent (US20210346831A1) technology that has a tremendous opportunity to tap into the market of air filtration systems. This market is expected to reach an estimated US$ 25.97 billion by 2030 and is expected to expand at a CAGR of 8.1 percent from 2022 to 2030, as outlined in a recent 'Research and Markets' report. The market is primarily driven by increasing air pollution levels, coupled with the outbreak of the COVID-19 pandemic and the rising awareness pertaining to the benefits of air purifiers.
Dr. Daniel Stolyarov, President & Co-CEO of G6 Materials Corp. commented, “We are thrilled to launch our highly anticipated Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System and excited about the prospects of commercializing our patented graphene based technology. Today’s launch of Breathe+ marks an important milestone for G6-Materials, as we continue to execute on our mission to deliver a retail consumer product, that is capable of making both our homes and offices a cleaner and safer environment. Graphene has proven to have extraordinary antiviral and antibacterial properties, making it more efficient in killing germs.
“Perhaps just as important a milestone for G6, our disruptive technology marks a new approach to air filtration that utilizes activated carbon with a coating of graphene oxide that can be easily scaled up for a wide range of industrial applications. We have tackled the complexity of air filtration with a robust evidence-based approach and will work to demonstrating our patented technology within many industrial sectors,” concluded Dr. Stolyarov.
Reference: Please click the following links to download the Intertek reports
About G6 Materials Corp.
G6 Materials Corp. is a high-tech company with expertise in advanced materials that creates value developing innovative composites for a wide range of industrial uses. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high-performance composites, and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. has entered the global air filtration market with Breathe+, a line of medical grade HEPA air filtration products enhanced with advanced performance graphene material.
G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprising five granted patents. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment.
The Company’s e-commerce websites are listed below:
- Breathe+: Medical grade HEPA air filtration enhanced with advanced performance graphene material, for more information, visit breatheplus.tech
- Conductive Epoxies: Adhesive materials distributed under the G6-EpoxyTM trade name and can be purchased at g6-epoxy.com
- R&D Materials: Graphene Laboratories Inc. currently offers over 100 graphene and related products available at graphene-supermarket.com
Telephone: (631) 405-5113
Email: [email protected]
Email: [email protected]
ON BEHALF OF THE BOARD: Daniel Stolyarov, President & Co-CEO
This news release contains forward-looking statements within the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes but is not limited to information about the graphene-enhanced air purifier (including efficacy, potential commercialization and patent pending thereof); information about the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.
The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
Risk factors that could cause actual results to differ materially include, but are not limited to, the risk that actual results in commercial applications of the graphene-enhanced air purifier may differ significantly from the Test Results; the Test Results may not be accepted by applicable regulatory agencies required to approve commercialization of the graphene-enhanced air purifier; the Company may not receive required approvals from regulatory agencies to commercialize the graphene-enhanced air purifier; the Company may not achieve further stages of commercialization of the graphene-enhanced air purifier as anticipated, or at all; the Company patent pending (US20210346831A1) may not be granted; the Company may not achieve anticipated commercial gains or profitability from the sale of Breathe+ Pro Advanced Antimicrobial Graphene Air Filtration System as currently anticipated, or at all; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; competition; dilution; and the volatility of our common share price and volume.
The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: G6 Materials Corp.